Powered by Lexis+®
Jurisdiction(s):
United Kingdom
CASE STUDY

“LexisPSL and the other Lexis solutions support our business in exactly the way we want. They enable us to quickly turn around work and deliver the best possible service to our clients.”

SBP Law

Access all documents on Common investment fund

Common investment fund meaning

What does Common investment fund mean?
A common investment fund in pensions practice is a structure by which two or more related occupational pension schemes, or segregated sections of a single multi-employer scheme, pool assets for collective investment management, usually through a unitised fund operated under trust. The expression is descriptive rather than defined in statute or case law. The governing trust deed (and any participation agreement) typically sets: allocation by units and valuation, admission and exit of participating schemes, cost and risk sharing, manager appointments, rebalancing, and reporting. It is used to deliver economies of scale, consistent investment strategy, improved governance and fee efficiencies, while allowing each scheme to keep separate benefit and funding arrangements. Each trustee board remains responsible for its own scheme’s investment decisions and must comply with fiduciary duties and pensions investment law (for example, the Occupational Pension Schemes (Investment) Regulations 2005 (GB) or the Northern Ireland equivalent; and, in Ireland, the Pensions Act 1990 (as amended)). Usage and legal approach are broadly consistent across England and Wales, Scotland, Northern Ireland and Ireland. In charity law, common investment fund can also describe pooled funds for multiple charities (including CAIFs), which are distinct from the pensions context.
Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business–all whilst saving time and reducing risk.

View the related News about Common investment fund

NEWS
Ireland asset management and investment funds update May 2025: CBI deadlines, ETF portfolio transparency, AIFMD II discretions, Hong Kong mutual recognition, AML/CFT consultations, sustainability disclosures, UK OFR landing slots.

Key deadlines 31 May 2025 - Fund profile return - Every Irish-authorised sub-fund must submit the annual Central Bank of Ireland (CBI) fund profile return for that year. The CBI Portal deadline for these sub‑fund profile returns has shifted from February to May 2025. In 2025, the CBI refreshed its fund profile guidance and template accordingly. 6 June 2025 - EBA consultations on AML/CFT RTS - The European Banking Authority (EBA) is seeking feedback on four draft RTS currently mandated by the EU’s new AML/CFT package, covering consistent ML/TF risk assessments, customer due diligence rules, the choice of institutions for direct oversight by AMLA, and penalties. The consultations formally close on 6 June 2025. 30 June 2025 - Exchange traded funds (ETFs) - ETF management companies should assess the steps set out in the CBI letter on ETF primary and secondary market trading arrangements (as discussed) and, where needed, embed the requisite adjustments into their frameworks and practices by end-Q2 2025. 30 June 2025...

Read More Right Arrow
NEWS
Life sciences weekly legal update: UK VPAG investment, EU CTR/IVDR changes, ICH paediatric extrapolation and MHRA/ICH RWD, RSV mRNA approval, CMA mergers, ASA rulings (29 August 2024)

In this issue: Research and development Medical devices Pharmaceuticals—regulatory framework Life sciences competition Advertising of medicines News alerts—daily and weekly Fresh and updated content Key dates for your diary Trackers Useful information Research and development UK unveils five‑year £400m public–private investment vehicle to bolster life sciences The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Life Sciences Investment Programme opened on 28 August 2024. This new joint public–private fund, worth up to £400m, is the first major collaboration of this scale globally. Over the next five years, it will strengthen clinical trials, enhance medicines manufacturing, and widen patient access to cutting‑edge therapies. The VPAG Investment Programme will establish 18 clinical trial hubs to accelerate getting new medicines to patients, allocating 75% of funding to expand commercial trial capacity (ie workforce and infrastructure, including the hubs), 20% to sustainable improvements in pharmaceutical manufacturing, and 5% to modernising Health Technology Assessment (HTA) methods...

Read More Right Arrow
NEWS
UK FTT: Pre-Brexit SIF VAT exemption; AIFMD comparability to UCITS accepted; COIFs exempt from 2014; LAPF and CBF not (CCLA Investment Management v HMRC)

CCLA Investment Management Ltd v HMRC [2024] UKFTT 636 (TC) CCLA supplied management services to investment funds whose investors included charities, Church of England bodies, and local authorities. These supplies had historically been treated as taxable, but the taxpayer later concluded they ought to have been exempt and submitted several claims for over-declared output VAT. The appeal covered thirteen funds, grouped into three categories: six COIFs six Church of England Central Board of Finance (CBF) Funds one Local Authorities’ Property Fund (LAPF) The applicable rules were those in force before the end of the Brexit transition period, and it was accepted that EU law had direct effect during that time. Consequently, the arguments concentrated on the EU provisions exempting the management of SIFs as defined by member states, rather than on UK domestic legislation. It was common ground that, prior to the end of the transition period, all investment funds constituted as UCITS—i.e. open-ended funds operating under the European UCITS regulatory...

Read More Right Arrow

View the related Practice Notes about Common investment fund

PRACTICE NOTES
2022 appeal round-up and tracker: key civil litigation decisions and forthcoming Supreme Court cases (England and Wales)

Practice Note This Practice Note consists of two strands created to help dispute resolution practitioners remain up to date with developments in case law that affect their field, or which influence civil litigation procedure more generally: selected forthcoming appeals to the Supreme Court are highlighted below; see Key forthcoming appeals to the Supreme Court—2022 summaries of significant appeal decisions in England and Wales (ie rulings of the Court of Appeal and Supreme Court and, where appropriate, certain judgments of the Competition Appeal Tribunal, Judicial Committee of the Privy Council, Court of Justice of the European Union), and ECtHR, which we have covered; see: Key forthcoming appeal cases—2022 You can navigate this content using the table of contents in the left-hand margin. Alternatively, search this tracker using [CTRL]+[F]. This material is not intended to be a comprehensive register of every appeal or major decision relevant to dispute resolution practitioners. Key forthcoming appeals to the Supreme Court—2022 Tort and negligence ...

Read More Right Arrow
PRACTICE NOTES
Valuing DB pension liabilities: scheme-specific funding (technical provisions) and low dependency, buy-out, PPF s143/s179, CETVs, IAS 19/UK GAAP and related funding concepts

THIS PRACTICE NOTE APPLIES IN RELATION TO DEFINED BENEFIT LIABILITIES How defined benefit (DB) liabilities ought to be assessed depends on a number of factors, in particular: the valuation approach to be adopted. Common exercises undertaken comprise the following: scheme-specific funding valuations as required under Part 3 of the Pensions Act 2004 (PeA 2004) solvency (or buy-out) valuations as required by the Occupational Pension Scheme (Scheme Funding) Regulations 2005, SI 2005/337, reg 7 valuations required by the PeA 2004, ss 143 and 179 (often described respectively as s 143 valuations and s 179 valuations) neutral estimates to meet the requirements of Technical Actuarial Standard 300 (Pensions) cash equivalent transfer values (CETV) as specified under the Occupational Pension Schemes (Transfer Values) Regulations 1996, SI 1996/1847 IAS19 and UK GAAP valuations whether the liabilities under review concern past service or future service, as distinct categories This Practice Note sets...

Read More Right Arrow
PRACTICE NOTES
US Volcker Rule: extraterritorial scope and impact on non‑US banking entities, proprietary trading ban, covered funds regime, compliance and reporting, and Economic Growth Act changes

Background to the Volcker Rule and implementation US regulators signed off regulations arising from the so‑called Volcker Rule elements of the Dodd‑Frank Wall Street Reform and Consumer Protection Act 2010 (Dodd‑Frank) on 10 December 2013, and the rules then came into force on 1 April 2014. At its core, the Volcker Rule removes the capacity of US banks to deal as principal in particular trading or investment fund‑related activities. The final rule also provided a conformance window running until 21 July 2015, allowing banking entities time to come into compliance with its prohibitions on proprietary trading and on covered fund ownership and sponsorship, as set out in the rule. General requirements of the final rule Section 619 of Dodd‑Frank inserted a new section 13 into the Bank Holding Company Act of 1956 (BHC Act). Under that section, in general terms, any banking entity is prohibited from engaging in proprietary trading, or from acquiring or retaining an ownership interest in, sponsoring, or having certain other relationships with a...

Read More Right Arrow

View the related Q&As about Common investment fund

Q&As
AEOI registration under 2025 ITC Amendments: specified non‑reporting trusts—trust corporations, trustee‑documented, and lay‑trustee private company shares

Amendments to the International Tax Compliance Regulations 2015 (2015 regs), SI 2015/878, introduced by the International Tax Compliance (Amendment) Regulations 2025, SI 2025/740, have brought in a compulsory Automatic Exchange of Information (AEOI) registration obligation for certain trusts treated as ‘specified non-reporting financial institutions’. Under the 2015 regs, SI 2015/878, reg 24(1), a specified non-reporting financial institution is ‘a non-reporting financial institution which is a trust within the meaning of Section VIII(B)(1)(e) of the CRS or paragraph II(D) of Annex II to the FATCA agreement’. Set out below is a concise overview of the components of that definition. Financial institution (IEIM400610) The FATCA and CRS frameworks recognise four common categories of Financial Institution: custodial institution depository institution investment entity specified insurance company Where a private trust satisfies any Financial Institution definition, it will most commonly be treated as an Investment Entity...

Read More Right Arrow